Last year, Canada made history when it became the 2 nd country in the world to legalize recreational cannabis by passing the Cannabis Act on June 19. The bill, officially dubbed C-45, went into effect on October 17, 2018. Although the exact provisions vary depending on province and territory, in general, the act allows Canadian citizens 18 or older to possess up to 30 grams of dried or undried flower and grow up to four plants per household.
This has led to some confusion and ambiguity regarding the legality of CBD in Canada. While medical CBD has been available Canadian citizens since 2001, patients were previously required to obtain approval from Health Canada (akin to the FDA in America) and a prescription to be able to purchase CBD products legally. When C-45 hit the one-year mark, it effectively permitted the marketing and sale of both recreational CBD and THC edibles and extracts, but many of these products are not expected to be widely available in the country until mid-December.
Is CBD Oil Legal in Canada?
These regulations, although undeniably necessary for a controlled substance, are not without inconvenience to many producers. The Cannabis Act leaves many stipulations up to the individual provinces of Canada, so regulations differ across localities. This has led to a surge in retail outlets in certain provinces (i.e. Alberta) while other areas, such as Ontario and Quebec, struggle to provide enough retail stores to meet demand.
It should be noted that many establishments, from health stores to dispensaries, are providing illicit CBD products in Canada. The government stresses that these products are illegal and unregulated, and purchased by consumers at their own risk.
The legalization of cannabis in Canada has not been without rigorous oversight. The Cannabis Act establishes strict regulations in the sale, possession, production, and distribution of cannabis. This includes a series of required licenses and permits for every establishment looking to market, grow or sell cannabis. It also limits the promotion of cannabis and cannabis-related products, particularly when it comes to marketing towards youth.
Author: Canadian Institute for Substance Use Research
Research suggests that CBD may provide relief for chronic pain. Sativex is a proprietary medication that combines THC and CBD and may be prescribed for the relief of pain associated with multiple sclerosis. There is also some evidence suggesting that CBD may be a promising support for people with opioid use disorders. The researchers noted that CBD reduced some symptoms associated with substance use disorders including anxiety, mood-related symptoms, pain, and insomnia.
What is the legal status (and evidence) of CBD oil?
Because of the way cannabis and its products are metabolized, scientists believe there is a potential for interaction with other drugs, although nothing significant has yet been recorded. CBD has been found to be generally safe. Reports from patients indicate that negative drug interactions are not common. As with any other treatment, it is important to monitor your use of CBD and seek assistance if you experience any problems or have questions or concerns about its use.
After researching the safety and effectiveness of CBD oil for treating epilepsy, in 2018, the United States FDA approved CBD (Epidiolex) as a therapy for two rare conditions characterized by epileptic seizures. Other evidence suggests that CBD may be useful in the treatment of schizophrenia, though further research is needed before introducing CBD into medical practice.
There is some initial evidence that CBD may help people in the early stages of Alzheimer’s disease keep the ability to recognize the faces of people that they know, and thus slow progression of the illness. Again, more research is needed in this area.
This licence could be:
Deliberately adding phytocannabinoids to such products is not permitted.
Producing and selling CBD
The provinces and territories are responsible for determining how cannabis is distributed and sold within their jurisdictions.
The flowering heads, branches and leaves may only be imported or exported by a licence holder under the Cannabis Regulations:
As a result, CBD and products containing CBD are subject to all of the rules and requirements that apply to cannabis under the Cannabis Act and its regulations. This includes CBD derived from industrial hemp plants, as well as CBD derived from other varieties of cannabis.